31 related articles for article (PubMed ID: 5428626)
1. Continuous infusion of recombinant activated factor VII: a review of data in congenital hemophilia with inhibitors and congenital factor VII deficiency.
Rajpurkar M; Cooper DL
J Blood Med; 2018; 9():227-239. PubMed ID: 30568523
[TBL] [Abstract][Full Text] [Related]
2. Comparison of continuous infusion versus bolus injection of factor concentrates for blood management after total knee arthroplasty in patients with hemophilia.
Park YS; Shin WJ; Kim KI
BMC Musculoskelet Disord; 2017 Aug; 18(1):356. PubMed ID: 28830476
[TBL] [Abstract][Full Text] [Related]
3. Total knee arthroplasty in severe haemophilic patients under continuous infusion of clotting factors.
Rahmé M; Ehlinger M; Faradji A; Gengenwin N; Lecocq J; Sibilia J; Bonnomet F
Knee Surg Sports Traumatol Arthrosc; 2012 Sep; 20(9):1781-6. PubMed ID: 22113216
[TBL] [Abstract][Full Text] [Related]
4. Effective management of intracranial haemorrhage with continuous infusion of highly purified von Willebrand factor/factor VIII complex concentrate in an adult with severe haemophilia A.
Daniele F; Rossi V; Santoro C
Blood Transfus; 2011 Oct; 9(4):472-4. PubMed ID: 21839022
[No Abstract] [Full Text] [Related]
5. Cost-utility analysis of primary prophylaxis versus treatment on-demand for individuals with severe haemophilia.
Miners AH; Sabin CA; Tolley KH; Lee CA
Pharmacoeconomics; 2002; 20(11):759-74. PubMed ID: 12201795
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of coagulation factors: clinical relevance for patients with haemophilia.
Björkman S; Berntorp E
Clin Pharmacokinet; 2001; 40(11):815-32. PubMed ID: 11735604
[TBL] [Abstract][Full Text] [Related]
7. Survival of 125iodine-labeled Factor VIII in normals and patients with classic hemophilia. Observations on the heterogeneity of human Factor VIII.
Over J; Sixma JJ; Bruïne MH; Trieschnigg MC; Vlooswijk RA; Beeser-Visser NH; Bouma BN
J Clin Invest; 1978 Aug; 62(2):223-34. PubMed ID: 670391
[TBL] [Abstract][Full Text] [Related]
8. Rationale and indications for continuous infusion of antihemophilic factor (factor VIII).
Goldsmith JC
Blood Coagul Fibrinolysis; 1996 Mar; 7 Suppl 1():S3-6. PubMed ID: 8735789
[TBL] [Abstract][Full Text] [Related]
9. Relationship between factor VIII replacement therapy and joint damage in severe haemophilia.
Lowe GD
Blood Coagul Fibrinolysis; 1997 Aug; 8 Suppl 1():S3-5. PubMed ID: 9351528
[TBL] [Abstract][Full Text] [Related]
10. Continuous intravenous infusion of factor VIII in classic haemophilia.
McMillan CW; Webster WP; Roberts HR; Blythe WB
Br J Haematol; 1970 Jun; 18(6):659-67. PubMed ID: 5428626
[No Abstract] [Full Text] [Related]
11. Home infusions for haemophilia.
S Afr Med J; 1973 Jan; 47(1):1. PubMed ID: 4686244
[No Abstract] [Full Text] [Related]
12. Epidural hemaoma in hemophilia: successful treatment.
Myles ST; Harris CE; Hansebout RR
Can Med Assoc J; 1971 Jan; 104(1):51-2. PubMed ID: 5540120
[No Abstract] [Full Text] [Related]
13. Intracranial surgery in hemophiliacs. Report of a case and review of the literature.
Olsen ER
Arch Neurol; 1969 Oct; 21(4):401-12. PubMed ID: 5821003
[No Abstract] [Full Text] [Related]
14. Conservative management of spinal epidural hematoma in hemophilia.
Narawong D; Gibbons VP; McLaughlin JR; Bouhasin JD; Kotagal S
Pediatr Neurol; 1988; 4(3):169-71. PubMed ID: 3149480
[TBL] [Abstract][Full Text] [Related]
15. Intraspinal bleeding in haemophilia: successful treatment with factor VIII concentrate.
Harvie A; Lowe GD; Forbes CD; Prentice CR; Turner J
J Neurol Neurosurg Psychiatry; 1977 Dec; 40(12):1220-3. PubMed ID: 591991
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
